Align Technology Inc (ALGN)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$180.65

Buy

$186.00

arrow-down$-2.11 (-1.15%)

Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.
Prices updated at 31 May 2025, 00:40 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
1,473m1,966m2,407m2,472m3,953m3,735m3,862m3,999m
1,117m1,448m1,744m1,763m2,935m2,634m2,707m2,799m
354m467m514m387m976m654m657m672m
24.0023.7321.3815.6624.7017.5117.0016.80
231m400m443m1,776m772m362m445m421m
391m521m593m481m1,085m780m799m817m
Sales, General and administrative666m852m1,072m1,201m1,709m1,674m1,703m1,763m
Interest expenses--------
Provision for income taxes130m58m112m-1,397m240m237m196m188m
Operating expenses763m981m1,229m1,376m1,959m1,980m2,050m2,127m
Income before taxes365m467m563m379m1,012m599m641m609m
Net income available to common shareholders231m400m443m1,776m772m362m445m421m
2.8955.5722.559.784.625.825.63
Net interest income7m9m12m3m3m5m17m20m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)2.834.925.5322.419.694.615.815.62
Free cash flow per share2.65542.90367.56454.482711.74654.42438.90234.9542
Book value/share14.767114.953816.645438.466544.6847.816350.640953.4111
Debt equity ratio--0.0322860.0199280.0283370.027860.0267090.022901

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets1,157m1,302m1,633m1,850m2,494m2,424m2,447m2,492m
Current liabilities498m692m971m1,326m1,924m1,926m2,067m2,038m
Total capital1,150m1,253m1,346m3,234m3,623m3,601m3,630m3,852m
Total debt--59m86m125m127m127m119m
Total equity1,150m1,253m1,346m3,234m3,623m3,601m3,630m3,852m
Total non current liabilities--------
Loans--------
Total assets1,778m2,052m2,501m4,830m5,942m5,948m6,084m6,215m
Total liabilities--------
Cash and cash equivalents450m637m550m961m1,099m942m937m1,044m
Common stock80m80m78m79m79m77m75m74m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period389m450m638m551m961m1,100m942m939m
Cash dividends paid--------
243m331m598m507m771m277m608m623m
Investments (gains) losses-248m7m-350m-232m-563m-213m-196m-255m
450m638m551m961m1,100m942m939m1,045m
Net income--------
439m555m747m662m1,173m569m786m738m
-196m-223m-150m-155m-401m-292m-178m-116m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.